WHC is still in active development. Read this to understand our approach.
depiction of JURKNVYFZMSNLP-UHFFFAOYSA-N.svg
tripsit

cyclobenzaprine

Check on tripsit

psychonaut

Cyclobenzaprine

Check on psychonaut

isomerdesign

Cyclobenzaprine

Check on isomerdesign

pubchem

Cyclobenzaprine

Check on pubchem

drugmap

Cyclobenzaprine

Check on drugmap

wiki

Cyclobenzaprine

Check on wiki

Data

InChI: InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3

Synonyms: 5-(3-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene,5-(3-dimethylaminopropylidene)- 5H-dibenzo[a,d]cycloheptene,Prestwick2_000445,NCGC00013841-19,apo-cyclobenzaprin,NCGC00013841-05,N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta5,gamma-propylamine,BDBM112774,dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene]propyl})amine, 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene,MK 130,MK-130 HCl,NCIStruc2_001486,DTXSID0046933,KBioGR_000643,Oprea1_534683,NSC78206,AB00514668,D07758, MK 130,BRD-K42348709-003-05-7,CAS-6202-23-9, Flexeril hydrochloride, Apo-Cyclobenzaprine (TN),(3-Dibenzo[a,d]cyclohepten-5-ylidene-propyl)-dimethyl-amine,ZINC968263,NCGC00013841-08, 3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine,flexeril,9715 R.P,AKOS025255657,KBio2_004583,303-53-7, 1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-(9CI),Prestwick0_000445,N,N-DIMETHYL-5H-DIBENZO(A,D)CYCLOHEPTENE-(SUP .DELTA.5,.GAMMA.)-PROPYLAMINE,10,11-Dehydroamitriptyline,69O5WQQ5TI,CYCLOBENZAPRINE [VANDF],NCGC00013841-03,3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, Flexeril (TN), Fexmid,5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene [Italian],KBio3_002572,5H-Dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine, N,N-dimethyl-,US8629135, SW-01,cyclobenzaprine,novo-cycloprine,Ciclobenzaprina,3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine,BPBio1_000540,BBL035415,Ro 4-1577, Yurelax,Q5198674,DivK1c_000047, NCI78206,N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine,RP 9715,Prestwick3_000445,NCGC00013841,1-Propanamine, 3-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-,BIDD:GT0485, 9715 R.P., 10,11-Dehydroamitriptyline,BSPBio_003072,Cyclobenzaprine, Proheptatrien, Cyclobenzaprinum [INN-Latin],Spectrum_001535,Spectrum5_001259,L001021, Cyclobenzaprine [INN],CHEMBL669, Proheptatriene,3-(dibenzo[1,2-a:1',2'-e][7]annulen-11-ylidene)-N,N-dimethylpropan-1-amine,Lisseril,MRF-0000742,SDCCGSBI-0050291.P005,BSPBio_000490,NCIStruc1_001572,Flexeril hydrochloride,KBio2_002015,AB00053651_07,MK-130,Proheptatrien,303C537,CHEBI:3996,SPBio_002429,3-(5H-DIBENZO(A,D)(7)ANNULEN-5-YLIDENE)-N,N-DIMETHYLPROPAN-1-AMINE,Fexmid, 5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene [Italian],Lopac-C-4542,GTPL7152,SPBio_001348, Proeptatriene,Prestwick1_000445,KBioSS_002015,CYCLOBENZAPRINE [MI], Lisseril, Ro 4-1577,HSDB 8305,FT-0603167,SBI-0050291.P003, 9715 R.P,Amrix (Salt/Mix),dimethyl(3-{tricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}propyl)amine,IDI1_000047,UNII-69O5WQQ5TI,N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine,NSC173379,BIDD:PXR0152, MK-130 HCl,CYCLOBENZAPRINE [USP IMPURITY], Fexmid(TN),Flexeril (Salt/Mix),NCGC00162122-01,NSC169900,AMITRIPTYLINE HYDROCHLORIDE IMPURITY B [EP IMPURITY],1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-,Proeptatriene, Cyclobenz,NCI60_041725,KBio1_000047,NORTRIPTYLINE HYDROCHLORIDE IMPURITY E [EP IMPURITY], Proeptatriene [Italian],STL416209,BRD-K42348709-003-08-1,NINDS_000047,Cyclobenzaprine hydrochloride (Salt/Mix),5-(3-Dimetilaminopropiliden)-5H-dibenzo-(a,d)-ciclopentene,TNX-102,Proheptatriene,3-(5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine,NCGC00013841-04,Spectrum4_000162,Ciclobenzaprina [INN-Spanish],NCI78206, Cyclobenzaprinum,Spectrum2_001534,Cyclobenzaprinum,EINECS 206-145-8,N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine,EN300-708806,Cyclobenzaprine [INN],DB00924,9715 R.P.,Proeptatriene [Italian],NCGC00096951-01,CCG-36511, N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine,C06931,NCGC00013841-02, Flexeril, N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine,3-(5H-Dibenzo[a,d]-cyclohepten-5-ylidene)-N,N-dimethylpropylamine,NCGC00013841-06,fexmid, Cyclobenzaprine (INN),Spectrum3_001566,Cyclobenzaprinum [INN-Latin], 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine,CYCLOBENZAPRINE [WHO-DD],Cyclobenzaprine (INN),3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine #, N,N-Dimethyl-3-(dibenzo(a,d)cycloheptene-4-ylidene)propylamine, 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, Amrix (TN),MK-130 (AS THE BASE),Lopac0_000303, Ciclobenzaprina [INN-Spanish],Cycloflex (Salt/Mix),N,N-Dimethyl-5H-dibenzo(a,d)cycloheptene-.delta.5,.gamma.-propylamine,KBio2_007151,5H-DIBENZO(a,d)CYCLOHEPTENE-delta(sup 5),gamma-PROPYLAMINE, N,N-DIMETHYL-,SCHEMBL38527,DB-047767,3-(dibenzo[[?],[?]][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine,QTL1_000027,N,N-dimethyl-5H-dibenzo(a,d)cycloheptene-Delta(5,gamma)-propylamine


Estimated data

Solubility: -4.175 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 50.2% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.